Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, Gonzalez-Lopez TJ, Grainger J, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780–817.
Article PubMed PubMed Central Google Scholar
Semple JW, Rebetz J, Maouia A, Kapur R. An update on the pathophysiology of immune thrombocytopenia. Curr Opin Hematol. 2020;27(6):423–9.
Article CAS PubMed Google Scholar
Wang N, Tall AR. Cholesterol in platelet biogenesis and activation. Blood. 2016;127(16):1949–53.
Article CAS PubMed PubMed Central Google Scholar
Slatter DA, Aldrovandi M, O’Connor A, Allen SM, Brasher CJ, Murphy RC, Mecklemann S, Ravi S, Darley-Usmar V, O’Donnell VB. Mapping the human platelet lipidome reveals cytosolic phospholipase A2 as a Regulator of mitochondrial bioenergetics during activation. Cell Metabol. 2016;23(5):930–44.
Münzer P, Walker-Allgaier B, Geue S, Langhauser F, Geuss E, Stegner D, Aurbach K, Semeniak D, Chatterjee M, Gonzalez Menendez I, et al. CK2β regulates thrombopoiesis and Ca-triggered platelet activation in arterial thrombosis. Blood. 2017;130(25):2774–85.
Morgan PK, Fang L, Lancaster GI, Murphy AJ. Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular diseases. J Lipid Res. 2020;61(5):667–75.
Article CAS PubMed Google Scholar
Cakirca G, Celik MM. Lipid profile and atherogenic indices and their association with platelet indices in familial Mediterranean fever. Turk Kardiyol Dern Ars. 2018;46(3):184–90.
Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, Matsumoto K, Hirata R, Domitsu K, Kobayashi M. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol. 2005;128(5):698–702.
Chen C, Song J, Wang Q, Wang L-H, Guo P-X. Mean platelet volume at baseline and immune thrombocytopenia relapse in chinese newly-diagnosed patients: a retrospective cohort study. Hematol (Amsterdam Netherlands). 2018;23(9):646–52.
Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925–6.
Georgakis MK, Gill D. Mendelian randomization studies in stroke: exploration of risk factors and drug targets with Human Genetic Data. Stroke. 2021;52(9):2992–3003.
Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrol. 2016;27(11):3253–65.
Article PubMed PubMed Central Google Scholar
Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for mendelian randomization. Stat Methods Med Res. 2017;26(5):2333–55.
Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16(4):309–30.
Elsworth B, Lyon M, Alexander T, Liu Y, Matthews P, Hallett J, Bates P, Palmer T, Haberland V, Smith GD et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv 2020:2020.2008.2010.244293.
Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, Mead D, Bouman H, Riveros-Mckay F, Kostadima MA, et al. The allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016;167(5):1415–1429e1419.
Article CAS PubMed PubMed Central Google Scholar
Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497–501.
Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, et al. Physical activity and risks of breast and colorectal cancer: a mendelian randomisation analysis. Nat Commun. 2020;11(1):597–7.
Article CAS PubMed PubMed Central Google Scholar
Shardell M, Ferrucci L. Instrumental variable analysis of multiplicative models with potentially invalid instruments. Stat Med. 2016;35(29):5430–47.
Article PubMed PubMed Central Google Scholar
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 2018, 7.
Fessler MB, Rose K, Zhang Y, Jaramillo R, Zeldin DC. Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population. J Lipid Res. 2013;54(11):3177–88.
Article CAS PubMed PubMed Central Google Scholar
Bora K, Jitani AK, Raphael V, Ruram AA, Borah P, Khonglah Y. Association between lipid profile and platelet indices: the importance of considering the influence of lipid profile while evaluating the clinical utility of platelet indices. Int J Lab Hematol. 2016;38(4):E80–3.
Article CAS PubMed Google Scholar
Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–80.
Qiu Y-J, Luo J-Y, Luo F, Tian X-X, Zeng L, Zhang Z-R, Li X-M, Yang Y-N. Prognostic value of the PDW/HDL-C ratio in patients with chest pain symptoms and coronary artery calcification. Front Cardiovasc Med. 2022;9:824955.
Article CAS PubMed PubMed Central Google Scholar
Kohlmorgen C, Gerfer S, Feldmann K, Twarock S, Hartwig S, Lehr S, Klier M, Krüger I, Helten C, Keul P, et al. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus. Diabetologia. 2021;64(8):1834–49.
Article CAS PubMed PubMed Central Google Scholar
Plubell DL, Fenton AM, Rosario S, Bergstrom P, Wilmarth PA, Clark WM, Zakai NA, Quinn JF, Minnier J, Alkayed NJ, et al. High-density lipoprotein carries markers that Track with Recovery from Stroke. Circul Res. 2020;127(10):1274–87.
Yao Y, Li X, Wang Z, Ji Q, Xu Q, Yan Y, Lv Q. Interaction of lipids, Mean platelet volume, and the severity of coronary artery disease among chinese adults: a mediation analysis. Front Cardiovasc Med. 2022;9:753171.
Article CAS PubMed PubMed Central Google Scholar
Şahin EA, Mavi D, Kara E, Sönmezer MÇ, İnkaya AÇ, Ünal S. Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years. Postgrad Med. 2022;134(6):635–40.
Wang Z, Wang W, Gong R, Yao H, Fan M, Zeng J, Xu S, Lin R. Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis. Lipids Health Dis. 2022;21(1):34.
Article CAS PubMed PubMed Central Google Scholar
Nagata Y, Yoshikawa J, Hashimoto A, Yamamoto M, Payne AH, Todokoro K. Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol. Genes Dev. 2003;17(23):2864–9.
Article CAS PubMed PubMed Central Google Scholar
Frelinger AL 3rd, Grace RF, Gerrits AJ, Berny-Lang MA, Brown T, Carmichael SL, Neufeld EJ, Michelson AD. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood. 2015;126(7):873–9.
Article CAS PubMed PubMed Central Google Scholar
Zhang S, Lv Y, Luo X, Weng X, Qi J, Bai X, Zhao C, Zeng M, Bao X, Dai X, et al. Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder. Mol Med. 2023;29(1):73.
Article CAS PubMed PubMed Central Google Scholar
de Pereira CJ, Flauzino WL, Alfieri T, Oliveira DF, Kallaur SR, Simão AP, Lozovoy ANC, Kaimen-Maciel MAB, Maes DR, Reiche M. Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: a follow-up study. J Neurol Sci. 2020;410:116630.
Ryu H, Kim J, Kim D, Lee J-E, Chung Y. Cellular and Molecular Links between autoimmunity and lipid metabolism. Mol Cells. 2019;42(11):747–54.
CAS PubMed PubMed Central Google Scholar
Xu P, Zhao Y, Yu T, Yu Y, Ni X, Wang H, Sun L, Han P, Wang L, Sun T et al. Atorvastatin restores imbalance of cluster of differentiation 4 (CD4) T cells in immune thrombocytopenia in vivo and in vitro. British journal of haematology 2021.
Kong Y, Cao X-N, Zhang X-H, Shi M-M, Lai Y-Y, Wang Y, Xu L-P, Chang Y-J, Huang X-J. Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients. Blood. 2018;131(11):1219–33.
Comments (0)